scispace - formally typeset
K

Kyung Mok Sohn

Researcher at Chungnam National University

Publications -  52
Citations -  1293

Kyung Mok Sohn is an academic researcher from Chungnam National University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 13, co-authored 47 publications receiving 999 citations. Previous affiliations of Kyung Mok Sohn include Samsung Medical Center & Konkuk University.

Papers
More filters
Journal ArticleDOI

Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity

TL;DR: Comparative and kinetic analyses revealed that high viral loads, weak antibody responses, and lymphopenia accompanying thrombocytopenia were associated with disease mortality, whereas persistent and gradual increases in lymphocyte responses might be required for effective immunity against MERS-CoV infection.
Journal ArticleDOI

COVID-19 Patients Upregulate Toll-like Receptor 4-mediated Inflammatory Signaling That Mimics Bacterial Sepsis.

TL;DR: It is reported here that toll-like receptor (TLR) 4-mediated inflammatory signaling molecules are upregulated in peripheral blood mononuclear cells from COVID-19 patients, compared with healthy controls (HC).
Journal ArticleDOI

Clinical Presentation and Outcomes of Middle East Respiratory Syndrome in the Republic of Korea

TL;DR: The clinical features of MERS-CoV infection in the Republic of Korea were similar to those of previous outbreaks in the Middle East, however, the overall mortality rate was lower than that in previous reports.
Journal ArticleDOI

MIR144* inhibits antimicrobial responses against Mycobacterium tuberculosis in human monocytes and macrophages by targeting the autophagy protein DRAM2

TL;DR: This study shows that Mtb significantly induces the expression of MIR144*/hsa-miR-144-5p, which targets the 3′-untranslated region of DRAM2 (DNA damage regulated autophagy modulator 2) in human monocytes and macrophages, and reveals that DR AM2 is a key coordinator of autophagic activation that enhances antimicrobial activity against Mtb.
Journal ArticleDOI

Impact of de-escalation therapy on clinical outcomes for intensive care unit-acquired pneumonia

TL;DR: In this paper, the authors evaluated clinical outcomes and risk factors related to de-escalation therapy in patients with intensive care unit (ICU)-acquired pneumonia, and showed that patients in the deescalation group showed a significantly lower pneumonia-related mortality rate compared to patients in a non-de-decision group.